Revolutionizing Fetal Monitoring. Saving Lives. Reducing C-Sections
Our patented fetal scalp sensor measures SpO2 in real-time, finally bringing oxygen data to the delivery room.
Misdiagnosis of Fetal Distress
False Positive FHR Alerts
Avg. Cost of Emergency C-Section
Total Addressable U.S. Market
1958
INVENTION OF THE FETAL
HEART MONITOR & CTG
(Cardiotocography)
2025
NOT MUCH HAS CHANGED
The Problem
Fetal heart rate (FHR) monitors fail to
properly identify fetal distress up to 50%
of the time, causing 2 major problems.
Overuse of emergency C-sections, due to
99% false positive rate.
Hypoxic-Ischemic Encephalopathy (HIE),
One of the most serious birth
complications.
Fetal SpO2 is still not monitored!
The Solution
Delivering a new vital
measurement of
Fetal Wellbeing during labor.
Market & Impact
Value proposition for:
- Hospitals: $8,000 savings per avoided C-section
- Physicians: More accurate decisions, less liability.
- Patients: Safer, evidence-based care.
The Team
Megan Missanelli, M.D & M.P.H
CEO & Co-Founder
Megan earned her Doctor of Medicine from the University of South Alabama where she also completed her residency in Obstetrics and Gynecology, earning numerous awards, including Intern of the Year, Best Obstetrics Resident, Best Gynecology Resident, and Best Laparoscopic Surgeon, also serving as Administrative Chief of her class responsible for the management of the 16 residents in her program.
Kirk Honour
Executive Director & Co-Founder
30+ years of medical device technology and entrepreneurial business experience bringing 12+ medical devices from concept to market, providing strategic “regulatory affairs” leadership and tactical development execution for multiple medical device companies including, Ecolab Inc., St Jude Medical Inc., American Medical Systems Inc. and Collagen Corporation.